CClinicalTrials.gg
CompletedNCT04195477Updated Nov 18, 2024

vDPP Facilitated With Community Care Coordination

An interventional study of vDPP in Diabetes Prevention, sponsored by Yale University. Completed at 2 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-11-18.

Sponsored by Yale University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
96
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The goal of the proposed Implementation Research project is to assess the feasibility of and pathways for implementation of a virtually-delivered DPP (v-DPP) supported by community-based care coordination facilitated by community health workers (CHWs) and hospital-based community nurses (HCNs). The goal of the intervention is to improve body weight, blood pressure, diet quality, and physical activity levels among low-income individuals at risk for type 2 diabetes.

Read the detailed description

Specific aims and hypotheses:

  1. Conduct formative research with community partners (via focus groups and interviews with key stakeholders and a small pilot) to assess community, systemic, technology, and structural level barriers to implementation of a virtually-delivered Diabetes Prevention Program.

    Hypothesis: These efforts will identify individual and community needs, barriers, and resources affecting the feasibility of v-DPP implementation. In addition, strategies for facilitating the delivery of the v-DPP to low-income communities will be developed.

  2. In collaboration with community partners, utilize strategies identified in Aim A1 to maximize impact of the v-DDP in target communities, as evidenced by measures of reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) and assess factors influencing RE-AIM outcomes (e.g. social determinants of health, demographic variables, self-efficacy).

    Hypothesis: The v-DPP facilitated by community-based care coordination will produce favorable RE-AIM outcomes. Factors influencing these outcomes will be explored as well.

  3. Demonstrate improvements in body weight, blood pressure, diet quality, and physical activity in low-income individuals at risk for type 2 diabetes who participate in a v-DPP facilitated by community-based care coordination.

    Hypothesis: The v-DPP, facilitated by community-based care coordination provided by CHWs and HCNs, will improve body weight, blood pressure, diet quality, and physical activity levels in the study communities.

  4. Collaborate with community partners to develop and implement a strategic approach to sustain the v-DPP facilitated by community-based care coordination in the study communities and translate it to other community settings.

Hypothesis: The implementation approach will be packaged, including strategies for implementation in different settings and related costs, providing a process for implementation in other low-income communities in our region and nationally.

02

Conditions studied

  • Diabetes Prevention
03

In context

Lead sponsor

Yale University is the lead sponsor of 1,724 studies on the registry; 298 are open to participants now.

Of its 210 completed or terminated interventional studies of FDA-regulated products, 126 (60%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • BMI ≥ 25 kg/m2, based on self-reported weight and height;
  • Eligible for Medicaid, as determined by self-reported income, household size, and Connecticut state guidelines for Medicaid eligibility;
  • At risk for prediabetes, as evidenced by a score of 5 points or higher on the CDC prediabetes risk screening test. [https://www.cdc.gov/prediabetes/takethetest/]
  • Participants in New Haven must also be residents of an ECC community (Housing Authority).
  • Participants in Derby and Ansonia must demonstrate proof of residency of either town (i.e., bill or other mail addressed to them).

Exclusion criteria

Exclusion Criteria:

  • Failure to meet inclusion criteria;
  • Anticipated inability to complete study protocol for any reason;
  • Self-reported current eating disorder;
  • Inability to exercise;
  • Non-English speaking;
  • Pregnant or planned pregnancy in next 12 months;
  • Self-reported diagnosis of type 1 or type 2 diabetes;
  • Failure to pass vDPP provider's required qualification step assessing readiness to change, when available.
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
96 participants (actual)

Study arms

  • Experimental
    vDPP Full Study

    Participants will take part in a 52 week study receiving the vDPP intervention.

    Behavioral: vDPP

Interventions

  • BehavioralvDPP

    virtual Diabetes Prevention Program

06

What researchers measure

Primary outcomes

  1. Change in BMI

    Body mass index (BMI) will be measured as a participant's weight in kilograms divided by his/her height in meters squared. Height will be collected by a RA/CHW/HCN using a stadiometer at baseline and at 4 weeks.

    Time frame: 16 weeks and 12 months

Secondary outcomes

  1. Change in Waist Circumference

    Waist circumference in centimeters will be collected at baseline and at 4 weeks.

    Time frame: 16 weeks and 12 months

  2. Change in Total Cholesterol

    Total cholesterol (Tchol) will be collected at baseline and at 4 weeks.

    Time frame: 16 weeks and 12 months

  3. Change in Triglycerides

    Triglycerides (TG) will be collected at baseline and at 4 weeks.

    Time frame: 16 weeks and 12 months

  4. Change in High-density Lipoprotein

    High-density lipoprotein (HDL) will be collected at baseline and at 4 weeks.

    Time frame: 16 weeks and 12 months

  5. Change in Diet Quality

    Dietary quality will be assessed at baseline and 4 weeks for the study. Participants will complete a 24-hour dietary recall using a web-based Automated Self-Administered 24-Hour Recall (ASA24) (available from the National Cancer Institute at ttp://riskfactor.cancer.gov/tools/instruments/asa24/), which will guide them through the process of completing the recall. Diet quality based on the information provided will be assessed using the Healthy Eating Index 2010 (HEI-2010).

    Time frame: 16 weeks and 12 months

  6. Change in Physical Activity

    Physical activity level (PA) will be assessed at baseline and 4 weeks for the study. The International Physical Activity Questionnaire (IPAQ). It is a comprehensive tool containing information on weekly household and yard-work activities, occupational activity, transport, leisure time physical activity, and sedentary behavior.

    Time frame: 16 weeks and 12 months

07

Study locations

2 sites
  • Griffin Hospital
    Derby, Connecticut 06418, United States
  • Yale University
    New Haven, Connecticut 06510, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04195477
Lead sponsor
Yale University
Collaborators
Centers for Disease Control and Prevention
Responsible party
Sponsor
First posted
Dec 12, 2019
Start date
Oct 7, 2020
Primary completion
Jul 31, 2024
Completion
Jul 31, 2024
Last update
Nov 18, 2024

Study contacts

Rafael Perez-Escamilla, PhD
principal investigator · Professor of Public Health, Director of the Office of Public Health Practice, and Director of the Global Health Concentration at the Yale School of Public Health

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion